Donald Trump: The Supreme Court’s ruling is regrettable; the tariff policy will remain in effect
U.S. President Donald Trump stated that the tariff policy will remain in effect, noting that tariffs will replace income taxes and that Congress does not need to take any action regarding them. Donald Trump expressed regret over the Supreme Court’s ruling and pointed out that nearly all countries and organizations wish to maintain the tariff agreements that have been reached.He praised the passage of the “Big and Beautiful” bill, noting that tips, overtime pay, and Social Security benefits will be exempt from taxation. He criticized Democrats for voting against massive tax cuts and in favor of significant tax hikes. Additionally, Donald Trump said he is addressing the heavy costs of healthcare and hopes to stop paying all funds to large insurance companies.
Source:富途快讯 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
3
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
4
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
5
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
6
Iran-linked exchange Shelbit allegedly sent $676 million to Binance in sanctions-evasion operation, Reuters reports
-
7
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
8
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
9
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
-
10
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
Markets Today
Recommended Reading







